This link will take you to a page that’s not on LinkedIn

Because this is an external link, we’re unable to verify it for safety.

https://www.businesswire.com/news/home/20260121486496/en/INTENT-Biologics-Receives-FDA-Agreement-Granting-a-Full-Waiver-for-its-Pediatric-Study-Plan-for-PEP-Biologic-in-Advanced-Wound-Care